Instrument Inactif

Communiqués Biotech Acquisition Company Nasdaq

Actions

BIOTU

KYG1125A1242

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

BIOTECH ACQUISITION CO : Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	02/02/23	AQ
Biotech Acquisition Company Announces Liquidation	02/02/23	GL
Biotech Acquisition Company Announces Liquidation	02/02/23	AQ
BIOTECH ACQUISITION CO : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	25/01/23	AQ
BIOTECH ACQUISITION CO : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	11/01/23	AQ
Biotech Acquisition Company Announces Plan for New Sponsor to Make Additional Contributions to Trust Account Upon Approval of Proposed Extension Amendment	04/01/23	PR
BIOTECH ACQUISITION CO : Entry into a Material Definitive Agreement (form 8-K)	22/12/22	AQ
BIOTECH ACQUISITION CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22/11/22	AQ
BIOTECH ACQUISITION CO : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	11/10/22	AQ
BIOTECH ACQUISITION CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22/08/22	AQ
Blade Therapeutics to Participate in “Drug Development in Pulmonary Medicine” Panel Discussion at 2022 BTIG Biotechnology Conference	01/08/22	BU
BIOTECH ACQUISITION CO : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	17/06/22	AQ
Biotech Acquisition : and Blade Therapeutics Mutually Agree to Terminate Business Combination Agreement - Form 8-K	13/06/22	PU
BIOTECH ACQUISITION CO : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	13/06/22	AQ
Biotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business Combination Agreement	13/06/22	PR
Biotech Acquisition : and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business Combination - Form 8-K	03/06/22	PU
BIOTECH ACQUISITION CO : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	03/06/22	AQ
Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business Combination	03/06/22	PR
Biotech Acquisition : and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business Combination - Form 8-K	31/05/22	PU
BIOTECH ACQUISITION CO : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	31/05/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Biotech Acquisition Company Nasdaq

Actions

BIOTU

KYG1125A1242

Communiqués

Filtres